ICLR
Icon Plc
stockNASDAQ
icon is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. we specialise in the strategic development, management and analysis of programmes that support clinical development - from compound selection to phase i-iv clinical studies. in a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis. we have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full service" solution. we are also an 'end-to-end' pharmacovigilance service provider and this includes post marketing surveillance activities too.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 185.43 | 2026-10-22 | +16.37% | 0.880 |
| 1M | 170.35 | 2026-09-29 | +26.67% | 1.054 |
| 3M | 178.18 | 2026-07-29 | +21.10% | -0.208 |
| 6M | 116.17 | 2026-04-29 | +85.75% | 0.485 |
| 1Y | 165.95 | 2025-10-29 | +30.03% | 1.325 |
| 2Y | 232.40 | 2024-10-29 | -7.15% | — |
| 5Y | 286.77 | 2021-10-29 | -24.75% | 1.110 |
Icon Plc (NASDAQ:ICLR) stock price today is $215.78, and today's volume is 1,550,139. ICLR is up 0.756% today. The 30 day average volume is 1.07M. ICLR market cap is $16.65B with 77.15M shares outstanding.